Version 5.4
Bos taurus Protein: SLC35A1
Summary
InnateDB Protein IDBP-684225.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol SLC35A1
Protein Name CMP-sialic acid transporter
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000018680
InnateDB Gene IDBG-632597 (SLC35A1)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
Predicted by orthology
Total 1 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005338 nucleotide-sugar transmembrane transporter activity
GO:0005351 sugar:proton symporter activity
Biological Process
GO:0006810 transport
GO:0008643 carbohydrate transport
GO:0015780 nucleotide-sugar transport
GO:0015992 proton transport
GO:0055085 transmembrane transport
GO:1901679 nucleotide transmembrane transport
Cellular Component
GO:0000139 Golgi membrane
GO:0016020 membrane
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID
InterPro IPR004689 UDP-galactose transporter
IPR007271 Nucleotide-sugar transporter
IPR013657 UAA transporter
IPR021189 UDP/CMP-sugar transporter
PFAM PF04142
PF08449
PRINTS
PIRSF PIRSF005799
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL Q3SZP1
UniProt Splice Variant
Entrez Gene 536838
UniGene Bt.44972
RefSeq NP_001029809
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL BC102765 DAAA02026478 DAAA02026479
GenPept AAI02766

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca